SomnoMed Ltd
RJV
Company Profile
Business description
SomnoMed Ltd is a public company providing treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux and SomTab. It produces and sells devices for the oral treatment of sleep-related disorders mainly in Asia Pacific, North America and Europe, with maximum revenue generated from Europe.
Contact
20 Clarke Street
Level 3
Crows Nest
SydneyNSW2065
AUST: +61 294670400
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
Employees
22
Stocks News & Analysis
stocks
Meta earnings: Early look at Muse adoption impresses investors
We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.
stocks
Tesla earnings: Shares fall on slower deliveries growth outlook; Raising valuation
Our increased valuation comes from higher full self-driving adoption assumptions and a lower near- and medium-term capital expenditures forecast.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,882.00 | 35.10 | -0.39% |
| CAC 40 | 7,811.26 | 110.42 | -1.39% |
| DAX 40 | 25,371.75 | 273.29 | -1.07% |
| Dow JONES (US) | 52,867.98 | 11.89 | 0.02% |
| FTSE 100 | 10,725.03 | 27.85 | -0.26% |
| HKSE | 22,934.68 | 717.19 | -3.03% |
| NASDAQ | 26,008.86 | 694.00 | -2.60% |
| Nikkei 225 | 62,159.41 | 748.43 | -1.19% |
| NZX 50 Index | 13,709.78 | 37.06 | -0.27% |
| S&P 500 | 7,663.43 | 93.74 | -1.21% |
| S&P/ASX 200 | 8,768.30 | 24.90 | -0.28% |
| SSE Composite Index | 3,658.03 | 55.00 | -1.48% |